Biologics Spine Top Stories Orthofix Announces Publication of Data Demonstrating the Clinical Benefits of Trinity Elite Cellular Bone Allograft in Lumbar Fusion Procedures byJosh SandbergDecember 22, 2022
Biologics Spine SeaSpine Announces Publication of Results from a Cellular Bone Graft Study in The Journal of Bone and Joint Surgery (JBJS) byChris StewartNovember 3, 2020
Biologics Royal Biologics announces the launch of MAGNUS, a DMSO-free viable cellular bone allograft byChris StewartJanuary 8, 2020
Biologics LifeNet Health Expands Operations in the Pacific Northwest to Include Production of ViviGen® Cellular Bone Matrix byJosh SandbergJanuary 11, 2017
Spine Orthofix Announces Publication of Data Demonstrating Benefits of Trinity Evolution Cellular Bone Allograft in Patients Undergoing Anterior Cervical Discectomy byJosh SandbergJuly 27, 2016
Biologics Preclinical Study Validates Science Behind AlloSource’s AlloStem Cellular Bone Allograft byJosh SandbergJuly 7, 2016
Financial Cellular Biomedicine Group Announces Closing of $43.13 Million Strategic Investment from Dangdai International Group Co., Limited, a Wholly-Owned Hong Kong Subsidiary of Wuhan Dangdai Science & Technology Industries Group Inc. byJosh SandbergApril 20, 2016
